Sunil Healthcare Limited (SUNLOC.BO)
- Previous Close
80.00 - Open
80.00 - Bid 82.00 x --
- Ask 82.80 x --
- Day's Range
80.00 - 83.00 - 52 Week Range
60.55 - 87.90 - Volume
53 - Avg. Volume
1,160 - Market Cap (intraday)
850.431M - Beta (5Y Monthly) -0.28
- PE Ratio (TTM)
-- - EPS (TTM)
-1.38 - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sunil Healthcare Limited engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally. Its products include EHG, BSE/TSE free, pearl, liquid fill, preservative free, stick free, flavored, SLS free, natural color, non-AZO, HPMC/vegetable, and pullulan capsules. The company also provides ayurvedic products, such as haldi, ginger, vasaka, trifala, guduchi, salaki, punarvana, shatavari, hadjod, hingwastak, mulethi, arjuna, ashwagandha, and guggul extracts. The company offers its products under the SUNLOC brand name. Sunil Healthcare Limited was incorporated in 1973 and is based in New Delhi, India.
www.sunilhealthcare.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: SUNLOC.BO
View MorePerformance Overview: SUNLOC.BO
Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SUNLOC.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SUNLOC.BO
View MoreValuation Measures
Market Cap
850.43M
Enterprise Value
1.50B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
1.27
Enterprise Value/Revenue
1.80
Enterprise Value/EBITDA
12.94
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.70%
Return on Assets (ttm)
1.52%
Return on Equity (ttm)
-2.09%
Revenue (ttm)
834.21M
Net Income Avi to Common (ttm)
-14.17M
Diluted EPS (ttm)
-1.38
Balance Sheet and Cash Flow
Total Cash (mrq)
30.85M
Total Debt/Equity (mrq)
102.35%
Levered Free Cash Flow (ttm)
-44.14M